دورية أكاديمية
Exome sequencing in children with clinically suspected maturity-onset diabetes of the young.
العنوان: | Exome sequencing in children with clinically suspected maturity-onset diabetes of the young. |
---|---|
المؤلفون: | Tosur M; Department of Pediatrics, The Section of Diabetes and Endocrinology, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas, USA., Soler-Alfonso C; Department of Molecular and Human Genetics, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas, USA., Chan KM; Department of Molecular and Human Genetics, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas, USA., Khayat MM; Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA., Jhangiani SN; Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA., Meng Q; Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA., Refaey A; Department of Biology and Biochemistry, University of Houston, Houston, Texas, USA., Muzny D; Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA., Gibbs RA; Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA., Murdock DR; Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA., Posey JE; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA., Balasubramanyam A; Division of Diabetes, Endocrinology and Metabolism, Baylor College of Medicine, Houston, Texas, USA., Redondo MJ; Department of Pediatrics, The Section of Diabetes and Endocrinology, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas, USA., Sabo A; Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA. |
المصدر: | Pediatric diabetes [Pediatr Diabetes] 2021 Nov; Vol. 22 (7), pp. 960-968. Date of Electronic Publication: 2021 Aug 19. |
نوع المنشور: | Case Reports; Journal Article; Research Support, N.I.H., Extramural |
اللغة: | English |
بيانات الدورية: | Publisher: Munksgaard Country of Publication: Denmark NLM ID: 100939345 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1399-5448 (Electronic) Linking ISSN: 1399543X NLM ISO Abbreviation: Pediatr Diabetes Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: Copenhagen : Munksgaard, c2000- |
مواضيع طبية MeSH: | Exome Sequencing*, Diabetes Mellitus, Type 2/*genetics, Adolescent ; Autoantibodies/blood ; Child ; Diabetes Mellitus, Type 1 ; Diagnosis, Differential ; Female ; Frameshift Mutation/genetics ; Genetic Variation ; Humans ; Islets of Langerhans/immunology ; Male ; Mutation, Missense/genetics ; Pedigree |
مستخلص: | Objective: Commercial gene panels identify pathogenic variants in as low as 27% of patients suspected to have MODY, suggesting the role of yet unidentified pathogenic variants. We sought to identify novel gene variants associated with MODY. Research Design and Methods: We recruited 10 children with a clinical suspicion of MODY but non-diagnostic commercial MODY gene panels. We performed exome sequencing (ES) in them and their parents. Results: Mean age at diabetes diagnosis was 10 (± 3.8) years. Six were females; 4 were non-Hispanic white, 5 Hispanic, and 1 Asian. Our variant prioritization analysis identified a pathogenic, de novo variant in INS (c.94G > A, p.Gly32Ser), confirmed by Sanger sequencing, in a proband who was previously diagnosed with "autoantibody-negative type 1 diabetes (T1D)" at 3 y/o. This rare variant, absent in the general population (gnomAD database), has been reported previously in neonatal diabetes. We also identified a frameshift deletion (c.2650delC, p.Gln884AsnfsTer57) in RFX6 in a child with a previous diagnosis of "autoantibody-negative T1D" at 12 y/o. The variant was inherited from the mother, who was diagnosed with "thin type 2 diabetes" at 25 y/o. Heterozygous protein-truncating variants in RFX6 gene have been recently reported in individuals with MODY. Conclusions: We diagnosed two patients with MODY using ES in children initially classified as "T1D". One has a likely pathogenic novel gene variant not previously associated with MODY. We demonstrate the clinical utility of ES in patients with clinical suspicion of MODY. (© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.) |
References: | Pediatr Diabetes. 2016 Aug;17(5):360-7. (PMID: 26059258) J Clin Endocrinol Metab. 2002 Jun;87(6):2532-9. (PMID: 12050210) Diabetes Care. 2021 Jan;44(Suppl 1):S15-S33. (PMID: 33298413) Diabetologia. 2018 Dec;61(12):2520-2527. (PMID: 30229274) J Clin Endocrinol Metab. 2013 Oct;98(10):4055-62. (PMID: 23771925) Diabetologia. 2004 Dec;47(12):2160-7. (PMID: 15592663) Pharmacogenomics J. 2015 Feb;15(1):49-54. (PMID: 25048417) Kidney Int. 2018 Jan;93(1):204-213. (PMID: 28893421) Proc Natl Acad Sci U S A. 2007 Sep 18;104(38):15040-4. (PMID: 17855560) Biochemistry. 2005 Apr 5;44(13):4984-99. (PMID: 15794637) Nature. 2010 Feb 11;463(7282):775-80. (PMID: 20148032) PLoS One. 2012;7(5):e38050. (PMID: 22662265) Diabet Med. 2015 Apr;32(4):526-30. (PMID: 25483937) Proc Natl Acad Sci U S A. 2009 Nov 10;106(45):19096-101. (PMID: 19861545) Nat Commun. 2017 Oct 12;8(1):888. (PMID: 29026101) Diabetes. 2004 May;53(5):1375-84. (PMID: 15111509) Diabet Med. 2020 Oct;37(10):1772-1776. (PMID: 31001871) Nat Protoc. 2015 Oct;10(10):1556-66. (PMID: 26379229) Diabet Med. 2009 May;26(5):466-73. (PMID: 19646184) BMC Bioinformatics. 2014 Jan 29;15:30. (PMID: 24475911) Diabetologia. 1998 Sep;41(9):1017-23. (PMID: 9754819) Nature. 2020 May;581(7809):434-443. (PMID: 32461654) NPJ Genom Med. 2016 Jan 13;1:. (PMID: 28567303) Epilepsia. 2019 Jan;60(1):155-164. (PMID: 30525188) N Engl J Med. 2010 Apr 1;362(13):1181-91. (PMID: 20220177) Am J Hum Genet. 2017 Oct 5;101(4):623-629. (PMID: 28985496) Diabetes. 2008 Apr;57(4):1131-5. (PMID: 18192540) Nat Genet. 2014 Aug;46(8):912-918. (PMID: 25017105) Genet Med. 2015 May;17(5):405-24. (PMID: 25741868) Front Genet. 2015 Aug 07;6:251. (PMID: 26300908) Diabetes Care. 2009 Oct;32(10):1864-6. (PMID: 19564454) Q J Med. 1974 Apr;43(170):339-57. (PMID: 4212169) Clin Endocrinol (Oxf). 2007 Oct;67(4):538-46. (PMID: 17573900) Diabetes. 2008 Apr;57(4):1034-42. (PMID: 18162506) Am J Hum Genet. 2016 Oct 6;99(4):877-885. (PMID: 27666373) Nat Genet. 2014 Mar;46(3):310-5. (PMID: 24487276) J Clin Invest. 1999 Jan;103(1):27-37. (PMID: 9884331) Nat Biotechnol. 2011 Jan;29(1):24-6. (PMID: 21221095) Development. 2010 Jan;137(2):203-12. (PMID: 20040487) J Pediatr Endocrinol Metab. 2015 Mar;28(3-4):251-63. (PMID: 25581748) Diabetologia. 2010 Dec;53(12):2504-8. (PMID: 20499044) Am J Hum Genet. 2015 Jul 2;97(1):177-85. (PMID: 26073777) Pediatr Diabetes. 2018 Jun;19(4):656-662. (PMID: 29417725) Diabetes. 2003 Mar;52(3):872-81. (PMID: 12606533) Diabetes Care. 2020 Apr;43(4):909-912. (PMID: 32001615) Genet Med. 2019 Jan;21(1):161-172. (PMID: 29907797) |
معلومات مُعتمدة: | K08 HG008986 United States HG NHGRI NIH HHS; R01 DK124395 United States DK NIDDK NIH HHS; UM1 HG008898 United States HG NHGRI NIH HHS |
فهرسة مساهمة: | Keywords: MODY; children; diabetes; exome sequencing; maturity onset diabetes of the young |
المشرفين على المادة: | 0 (Autoantibodies) |
تواريخ الأحداث: | Date Created: 20210813 Date Completed: 20220203 Latest Revision: 20240615 |
رمز التحديث: | 20240615 |
مُعرف محوري في PubMed: | PMC8530905 |
DOI: | 10.1111/pedi.13257 |
PMID: | 34387403 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1399-5448 |
---|---|
DOI: | 10.1111/pedi.13257 |